Clinical trials
Observational Sinusitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 7 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oregon Health and Science University | 3 |
| GlaxoSmithKline | 2 |
| Greg Davis | 2 |
| Integra LifeSciences Corporation | 2 |
| University of California, Irvine | 2 |
| University of Jena | 2 |
| Aardvark Medical Company | 1 |
| Assiut University | 1 |
| Bayer | 1 |
| Bitop AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sinusitis | 40 |
| Bronchiolitis Obliterans Syndrome | 4 |
| Disease | 3 |
| Nasal Polyps | 3 |
| Bronchitis | 2 |
| Cystic Fibrosis | 2 |
| Facial Pain | 2 |
| Paranasal Sinus Diseases | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Respiratory Tract Infections | 2 |
Trials
Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.